Uptake and effectiveness of a mobile application for real-time reporting and quality assurance of decentralized SARS-CoV-2 testing in Uganda

被引:0
|
作者
Nansumba, Hellen [1 ]
Nambuya, Proscovia [1 ]
Wafula, Jackson [1 ]
Laiton, Namutebi [1 ]
Kadam, Rigveda [2 ]
Akinwusi, Olukunle [2 ]
Suleiman, Khairunisa [2 ]
Akugizibwe, Paula [2 ]
Ssewanyana, Isaac [1 ]
机构
[1] Minist Hlth, Cent Publ Hlth Labs, Kampala, Uganda
[2] Fdn Innovat New Diagnost FIND, Geneva, Switzerland
关键词
COVID-19; decentralized diagnosis; digital; data; surveillance; quality assurance;
D O I
10.3389/fpubh.2023.1053544
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundEffective management of the COVID-19 pandemic required rapid expansion of diagnosis. The introduction of antigen tests presented an opportunity to decentralize testing, but raised challenges with ensuring accurate and timely reporting of testing data, which is essential to guide the response. Digital solutions can help address this challenge and provide more efficient means of monitoring and quality assurance. MethodsUganda's existing laboratory investigation form was digitized in the form of an Android-based application, eLIF, which was developed by the Central Public Health Laboratory and implemented in 11 high-volume facilities between December 2021 and May 2022. The app enabled healthcare workers to report testing data via mobile phone or tablet. Uptake of the tool was monitored through a dashboard that enabled real-time visibility into data being transmitted from sites, as well as qualitative insights from site visits and online questionnaires. Results and discussionA total of 15,351 tests were conducted at the 11 health facilities during the study period. Of these, 65% were reported through eLIF, while 12% were reported through preexisting Excel-based tools. However, 23% of tests were only captured in paper registers and not transmitted to the national database, illustrating the need for increased uptake of digital tools to ensure real-time data reporting. While data captured through eLIF were transmitted to the national database within 0-3 days (min, max), data transmitted through Excel were transmitted in within 0-37 days (min, max), and data for paper-based reporting took up to 3 months. The majority of healthcare workers interviewed in an endpoint questionnaire responded that eLIF improved timeliness of patient management, and reduced reporting time. However, some functions of the app were not successfully implemented, such as providing random selections of samples for external quality assurance and enabling seamless linkage of these data. Challenges arose from broader operational complexities, such as staff workload, frequent task-shifting and unexpected changes to facility workflows, which limited adherence to the envisioned study procedures. Ongoing improvements are needed to adjust to these realities, to strengthen the technology and support to healthcare workers using it, to optimize the impact of this digital intervention.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Performance and cost-effectiveness of a pooled testing strategy for SARS-CoV-2 using real-time polymerase chain reaction in Uganda
    Bogere, Naghib
    Bongomin, Felix
    Katende, Andrew
    Ssebambulidde, Kenneth
    Ssengooba, Willy
    Ssenfuka, Henry
    Kigozi, Edgar
    Biraro, Samuel
    Kateete, David P.
    Andia-Biraro, Irene
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 113 : 355 - 358
  • [2] Exploring Workplace Testing with Real-Time Polymerase Chain Reaction SARS-CoV-2 Testing
    Fuentes, Lucas
    Shah, Nigam
    Kelly, Sara
    Harnett, Glenn
    Schulman, Kevin A.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2022, 35 (01) : 96 - 101
  • [3] SARS-CoV-2 Variants Monitoring Using Real-Time PCR
    Esman, Anna
    Cherkashina, Anna
    Mironov, Konstantin
    Dubodelov, Dmitry
    Salamaikina, Svetlana
    Golubeva, Anna
    Gasanov, Gasan
    Khafizov, Kamil
    Petrova, Natalya
    Cherkashin, Evgeniy
    Akimkin, Vasiliy
    DIAGNOSTICS, 2022, 12 (10)
  • [4] Real-time environmental surveillance of SARS-CoV-2 aerosols
    Puthussery, Joseph V. V.
    Ghumra, Dishit P. P.
    McBrearty, Kevin R. R.
    Doherty, Brookelyn M. M.
    Sumlin, Benjamin J. J.
    Sarabandi, Amirhossein
    Mandal, Anushka Garg
    Shetty, Nishit J. J.
    Gardiner, Woodrow D. D.
    Magrecki, Jordan P. P.
    Brody, David L. L.
    Esparza, Thomas J. J.
    Bricker, Traci L. L.
    Boon, Adrianus C. M.
    Yuede, Carla M. M.
    Cirrito, John R. R.
    Chakrabarty, Rajan K. K.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [5] Diagnosing SARS-CoV-2 with Antigen Testing, Transcription-Mediated Amplification and Real-Time PCR
    Dierks, Sascha
    Bader, Oliver
    Schwanbeck, Julian
    Gross, Uwe
    Weig, Michael S.
    Mese, Kemal
    Lugert, Raimond
    Bohne, Wolfgang
    Hahn, Andreas
    Feltgen, Nicolas
    Torkieh, Setare
    Denker, Fenja R.
    Lauermann, Peer
    Storch, Marcus W.
    Frickmann, Hagen
    Zautner, Andreas Erich
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [6] SARS-CoV-2 direct real-time polymerase chain reaction testing in laboratories with shortage challenges
    Alaifan, Taghreed
    Altamimi, Asmaa
    Obeid, Dalia
    Alshehri, Turki
    Almatrrouk, Shaihana
    Albarrag, Ahmed
    FUTURE VIROLOGY, 2021, 16 (02) : 133 - 140
  • [7] The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology
    Oude Munnink, Bas B.
    Worp, Nathalie
    Nieuwenhuijse, David F.
    Sikkema, Reina S.
    Haagmans, Bart
    Fouchier, Ron A. M.
    Koopmans, Marion
    NATURE MEDICINE, 2021, 27 (09) : 1518 - 1524
  • [8] Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
    Maeda, Haruka
    Saito, Nobuo
    Igarashi, Ataru
    Ishida, Masayuki
    Terada, Mayumi
    Ito, Takayasu
    Ikeda, Hideko
    Kamura, Hiroshi
    Motohashi, Iori
    Kimura, Yuya
    Komino, Masaru
    Arai, Hiromi
    Kuwamitsu, Osamu
    Akuzawa, Nobuhiro
    Sando, Eiichiro
    Morikawa, Toru
    Imura, Haruki
    Inoue, Hiroki
    Hayakawa, Tomoichiro
    Teshigahara, Osamu
    Ohara, Yasuji
    Suzuki, Motoi
    Morimoto, Konosuke
    EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 288 - 298
  • [9] Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study
    Paradiso, Angelo Virgilio
    De Summa, Simona
    Loconsole, Daniela
    Procacci, Vito
    Sallustio, Anna
    Centrone, Francesca
    Silvestris, Nicola
    Cafagna, Vito
    De Palma, Giuseppe
    Tufaro, Antonio
    Garrisi, Vito Michele
    Chironna, Maria
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (10)
  • [10] Lessons learned: use of WGS in real-time investigation of suspected intrahospital SARS-CoV-2 outbreaks
    Berggreen, H.
    Lovestad, A. H.
    Helmersen, K.
    Jorgensen, S. B.
    Aamot, H. V.
    JOURNAL OF HOSPITAL INFECTION, 2023, 131 : 81 - 88